The combined eŠect of terpinen-4-ol, the main component of tea tree oil, and capric acid against mycelial growth of Candida albicans and murine oral candidiasis was evaluated in vitro and in vivo. Mycelial growth of C. albicans was estimated by the Cristal violet method. Combination of these compounds revealed a potent synergistic inhibition of growth. Therapeutic e‹cacy of the combination was evaluated microbiologically in murine oral candidiasis, and its application of the compounds clearly demonstrated therapeutic activity. Based on these results, the combined agent of terpinen-4-ol and capric acid was discussed as a possible candidate for oral candidiasis therapy. 
Concentrations of capric acid are as follows:
• 0 mg/mL, ■ 0.195 mg/ mL, ▲ 0.39 mg/mL, × 0.78 mg/mL, ＋ 1.56 mg/mL, ■ 3.13 mg/mL. Anti-Candida e‹cacy of terpinen-4-ol and capric acid was evaluated with micro dilution method. Terpinen-4-ol was applied vertically and capric acid was applied horizontally. Combination of terpinen-4-ol 10 mg/mL and capric acid 0.625 mg/mL showed additive e‹cacy whose FICindex was calculated to be 0.75.
Fig. 4. Therapeutic E‹cacy of Terpinen-4-ol and/or Capric Acid for Murine Oral Candidiasis
Therapeutic e‹cacy of terpinen-4-ol and capric acid in murine oral candidiasis infected by TIMM1768 was evaluated. Each of agents was applied at 3, 24 and 27 h after Candida inoculation. On day 2, symptom score of tongue and colony forming units were determined as described in Material and Methods. 
